Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karolina Łuczkowska

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|May 11, 2018
Extracellular vesicles in hematological malignanciesZofia Litwińska, Karolina Łuczkowska, Bogusław Machaliński
International Journal of Molecular Sciences|January 26, 2020
Effect of Bortezomib on Global Gene Expression in PC12-Derived Nerve CellsKarolina Łuczkowska, Dorota Rogińska, Zofia Ulańczyk, et al.
Nutrients|January 11, 2024
Vitamin D and K Supplementation Is Associated with Changes in the Methylation Profile of U266-Multiple Myeloma Cells, Influencing the Proliferative Potential and Resistance to BortezomibKarolina Łuczkowska, Piotr Kulig, Bartłomiej Baumert, et al.
Nutrients|December 11, 2022
The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to BortezomibKarolina Łuczkowska, Piotr Kulig, Bartłomiej Baumert, et al.
Leukemia & Lymphoma|August 24, 2022
Brain-derived neurotrophic factor: focus on the pathogenesis of multiple myeloma and the development of treatment-induced peripheral neuropathyKarolina Łuczkowska, Piotr Kulig, Bartłomiej Baumert, et al.
Scientific Reports|October 9, 2024
Deep hematologic response to RD treatment in patients with multiple myeloma is associated with overexpression of IL-17R in CD138+ plasma cellsPiotr Kulig, Karolina Łuczkowska, Bogusław Machaliński, et al.
International Journal of Molecular Sciences|December 9, 2023
5-Aza-2'-Deoxycytidine Alters the Methylation Profile of Bortezomib-Resistant U266 Multiple Myeloma Cells and Affects Their Proliferative PotentialKarolina Łuczkowska, Piotr Kulig, Klaudia Rusińska, et al.
Cancers|January 11, 2024
Epigenetic Alterations as Vital Aspects of Bortezomib Molecular ActionPiotr Kulig, Karolina Łuczkowska, Estera Bakinowska, et al.
Nutrients|May 14, 2022
Vitamin D as a Potential Player in Immunologic Control over Multiple Myeloma Cells: Implications for Adjuvant TherapiesPiotr Kulig, Karolina Łuczkowska, Anna Bielikowicz, et al.
International Journal of Molecular Sciences|March 10, 2022
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy DevelopmentKarolina Łuczkowska, Dorota Rogińska, Piotr Kulig, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|May 11, 2018
Extracellular vesicles in hematological malignanciesZofia Litwińska, Karolina Łuczkowska, Bogusław Machaliński
International Journal of Molecular Sciences|January 26, 2020
Effect of Bortezomib on Global Gene Expression in PC12-Derived Nerve CellsKarolina Łuczkowska, Dorota Rogińska, Zofia Ulańczyk, et al.
Nutrients|January 11, 2024
Vitamin D and K Supplementation Is Associated with Changes in the Methylation Profile of U266-Multiple Myeloma Cells, Influencing the Proliferative Potential and Resistance to BortezomibKarolina Łuczkowska, Piotr Kulig, Bartłomiej Baumert, et al.
Nutrients|December 11, 2022
The Evidence That 25(OH)D3 and VK2 MK-7 Vitamins Influence the Proliferative Potential and Gene Expression Profiles of Multiple Myeloma Cells and the Development of Resistance to BortezomibKarolina Łuczkowska, Piotr Kulig, Bartłomiej Baumert, et al.
Leukemia & Lymphoma|August 24, 2022
Brain-derived neurotrophic factor: focus on the pathogenesis of multiple myeloma and the development of treatment-induced peripheral neuropathyKarolina Łuczkowska, Piotr Kulig, Bartłomiej Baumert, et al.
Scientific Reports|October 9, 2024
Deep hematologic response to RD treatment in patients with multiple myeloma is associated with overexpression of IL-17R in CD138+ plasma cellsPiotr Kulig, Karolina Łuczkowska, Bogusław Machaliński, et al.
International Journal of Molecular Sciences|December 9, 2023
5-Aza-2'-Deoxycytidine Alters the Methylation Profile of Bortezomib-Resistant U266 Multiple Myeloma Cells and Affects Their Proliferative PotentialKarolina Łuczkowska, Piotr Kulig, Klaudia Rusińska, et al.
Cancers|January 11, 2024
Epigenetic Alterations as Vital Aspects of Bortezomib Molecular ActionPiotr Kulig, Karolina Łuczkowska, Estera Bakinowska, et al.
Nutrients|May 14, 2022
Vitamin D as a Potential Player in Immunologic Control over Multiple Myeloma Cells: Implications for Adjuvant TherapiesPiotr Kulig, Karolina Łuczkowska, Anna Bielikowicz, et al.
International Journal of Molecular Sciences|March 10, 2022
Bortezomib-Induced Epigenetic Alterations in Nerve Cells: Focus on the Mechanisms Contributing to the Peripheral Neuropathy DevelopmentKarolina Łuczkowska, Dorota Rogińska, Piotr Kulig, et al.
Pageof 6